Featured Image
Perspectives
I have decades of experience evaluating medicines from a payers perspective. This article adds to that body of knowledge.
Mr Ronald A Lyon
Hampton University
Read the Original
This page is a summary of: Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction, Vascular Health and Risk Management, April 2016, Dove Medical Press,
DOI: 10.2147/vhrm.s82387.
You can read the full text:
Contributors
The following have contributed to this page
